FRANKFURT--(BUSINESS WIRE)--Merz Pharma Group today announced the successful completion of the $5.45 per share cash tender offer for all outstanding shares of BioForm Medical, Inc. (Nasdaq: BFRM) made by Merz GmbH & Co. KGaA (“Merz”) and its acquisition subsidiary. The tender offer expired at 12:00 midnight, Eastern Standard Time, on February 12, 2010.
